Targeted Delivery of PLK1-siRNA by Single-Chain Antibody Suppresses Her2+ Breast Cancer Growth and MetastasisTuesday, 26 April 2011 at 16:30  Add to Calendar ▼2011-04-26 16:30:002011-04-26 17:30:00Europe/LondonTargeted Delivery of PLK1-siRNA by Single-Chain Antibody Suppresses Her2+ Breast Cancer Growth and MetastasisRNAi and miRNA World Congress in BostonBostonSELECTBIOenquiries@selectbiosciences.comThe intravenously injected siRNA complexes retarded Her2+ breast tumor growth, reduced metastasis and prolonged survival without evident toxicity. These data suggest that Her2-ScFv-protamine peptide fusion protein could be used to deliver siRNAs to treat Her2+ breast cancer. |
Add to Calendar ▼2011-04-26 00:00:002011-04-27 00:00:00Europe/LondonRNAi and miRNA World CongressRNAi and miRNA World Congress in BostonBostonSELECTBIOenquiries@selectbiosciences.com
